Zymeworks Secures $250 Mln Royalty Funding Deal With Royalty Pharma
(RTTNews) - Zymeworks Inc. (ZYME), a clinical-stage biopharmaceutical company, on Monday entered into a $250 million royalty funding agreement with Royalty Pharma plc (RPRX), a buyer of...
Nasdaq News: Markets·4h ago